Authority: IC 25-26-13-4

Affected: IC 25-26-13

Sec. 1. (a) As used in this rule, "cognitive services" means those services provided by a licensed pharmacist (or registered pharmacist intern under the supervision of a licensed pharmacist) that involve the delivery of patient care, counseling, or professional advice that may facilitate pharmaceutical care. The term includes, but is not limited to, the following functions:

1. (1) Medication therapy management.
2. (2) Prospective drug review.
3. (3) Drug utilization review.
4. (4) Drug interaction review.
5. (5) Collaborative practice with eligible prescribers.
6. (6) Pharmacist prescribing where permissible under collaborative practice.
7. (7) Patient counseling (whether in person or via technology that allows the pharmacist to have real-time access to patient data and real-time visual or vocal contact with the patient).
8. (8) Patient education and outreach designed to improve patient outcomes.
9. (9) Facilitating patient medication compliance and adherence.
10. (10) Facilitating preventative health or disease state management programs.
11. (11) Reducing medication errors.
12. (12) Review and analysis of records of continuous quality improvement programs or protocols.

(b) The term does not include the following activities:

1. (1) Administrative or clerical functions.
2. (2) Third party claims.
3. (3) Sales calls.
4. (4) Record keeping not required to be performed by a pharmacist.
5. (5) Reporting not required to be performed by a pharmacist.
6. (6) Provision of customer service not related to patient counseling on a prescription or drug order review.
7. (7) Duties related to preparation and dispensing of a prescription or drug order that will result in ultimate review by a licensed pharmacist.

(Indiana Board of Pharmacy; 856 IAC 1-41-1; filed Jun 19, 2013, 10:06 a.m.: 20130717-IR-856120619FRA; readopted filed Nov 18, 2019, 11:41 a.m.: 20191218-IR-856190076RFA; readopted filed Feb 15, 2024, 1:16 p.m.: 20240313-IR- 856230795RFA)